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KORELASI DI ANTARA PERUBAHAN ISKEMIA SEREBRUM JISIM 
PUTIH DAN PROFIL NEUROKOGNITIF DALAM INDIVIDU 
ASIMPTOMATIK  
 
ABSTRAK 
 
Hiperintensiti jirim putih (WMHs), asimptomatik ‗lacunar infarcts‘,  pendarahan 
kecil otak (BMBs) dan ruang perivaskular yang diperbesarkan (EPVS) telah dikenal 
pasti sebagai lesi senyap yang boleh dikaitkan penyebab kepada penyakit pembuluh 
darah kecil otak (CSVD). Semua petanda ini telah dikaitkan secara individu untuk 
kecenderungan kemerosotan nilai kognitif. Kajian ini bertujuan untuk mengkaji 
hubungan antara CSVD dari penemuan MRI dan prestasi neuropsikologi di kalangan 
individu yang kelihatannya sihat. Kelulusan etika telah diperolehi daripada 
Jawatankuasa Etika Penyelidikan Manusia Universiti Sains Malaysia (JEPeM-USM) 
[Ruj: USM / JEPeM / 15030096]. Ini merupakan satu kajian perintis dengan 
anggaran saiz sampel, yang berasaskan penyelidikan berkaitan sebelumnya. Subjek 
dipilih daripada populasi rawak yang menghadiri Klinik Rawatan Keluarga (KRK), 
Hospital Universiti Sains Malaysia (HUSM), dengan umur dan jantina dipadankan. 
QRISK2, iaitu ramalan risiko kardiovaskular berasaskan dalam talian telah 
digunakan untuk menentukan tahap risiko kardiovaskular subjek yang mengambil 
bahagian dalam kajian. Enam puluh (n=60) subjek yang memenuhi kriteria inklusi 
dan ekslusi, telah diambil dan menjalani imbasan otak iaitu Pengimejan Resonans 
Magnet (MRI) menggunakan pengimbas Philips 3-Tesla Achieva MR, serta 
menyiapkan penilaian neuropsikologi menggunakan Weschsler Adult Intelligence 
x 
 
Scale –Edisi keempat (WAIS-IV) (2008). Imej-imej asas MRI digunakan untuk 
menentukan kewujudan WMHs dan dikira menggunakan skala Fazekas. Ujian 
neuropsikologi dilakukan ke atas tiga skala indeks seperti Indeks Penaakulan 
Persepsi (PRI), Indeks Memori Kerja (WMI) dan Indeks Kelajuan Pemprosesan 
(PSI). Analisis telah dilakukan menggunakan IBM SPSS Statistik versi 22.0. 
Daripada enam puluh subjek (18 lelaki dan 42 perempuan) yang berumur antara 25 
hingga 62 tahun yang telah direkrut, kira-kira 30% daripada mereka mempunyai 
sejarah keluarga yang mempunyai penyakit jantung, 10% dalam rawatan tekanan 
darah tinggi dan 60% tanpa komorbiditi. Dikalangan subjek, 23 orang (38.3%) 
daripada mereka mempunyai WHMs yang dikesan oleh MRI, dan selebihnya adalah 
normal. Di kalangan subjek yang mempunyai WMHs, 39.1% adalah dalam usia 
muda (25-39) dan 60.9% berada di pertengahan umur (40-62). Data primer 
mencadangkan bahawa skor ujian neuropsikologi adalah berubah-ubah antara subjek 
yang mempunyai WMHs, dengan kecenderungan kawasan otak. Terdapat kaitan 
yang signifikan antara subjek yang mempunyai atau tidak mempunyai WHMs dalam 
PRI, t (0.07,58)=0.07, p=0.02. Oleh itu, umur (r = 0.3, p <0.05) dan skor QRISK (r = 
0.4, p <0.05) didapati berhubung kait dengan kehadiran WMHs. Keputusan ini 
menunjukkan bahawa di kalangan warga tua, CSVD boleh menyumbang kepada 
penurunan kognitif dengan mempengaruhi kelajuan pemprosesan maklumat dan 
fungsi eksekutif. Memandangkan kehadiran WMHs mungkin juga menunjukkan 
peningkatan risiko kejadian gejala serebrovaskular, dengan itu pentafsiran yang teliti 
diperlukan untuk menentukan perkaitan klinikal untuk setiap individu.  
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CORRELATIONS BETWEEN ISCHAEMIC CEREBRAL WHITE MATTER 
CHANGES AND THE NEUROCOGNITIVE PROFILES IN APPARENTLY 
ASYMPTOMATIC INDIVIDUALS  
 
ABSTRACT 
 
White matter hyperintensities (WMHs), asymptomatic lacunar infarcts, brain 
microbleeds (BMBs), and enlarged perivascular spaces (EPVS) have been identified 
as silent lesions attributable to cerebral small vessel disease (CSVD). All these 
markers have been individually linked to predisposition of cognitive impairment. 
This study aimed to examine the relationship between CSVD from incidental MRI 
findings and neuropsychological performance among apparently healthy individuals. 
An ethical approval was obtained from the Jawatankuasa Etika Penyelidikan 
Manusia Universiti Sains Malaysia (JEPeM-USM) [Ref: USM/JEPeM/15030096]. 
This was a pilot study that involved random selection of subjects‘ population who 
attended Klinik Rawatan Keluarga, Hospital Universiti Sains Malaysia. The 
QRISK2, an online-based cardiovascular risk prediction was employed to stratify the 
cerebrovascular risk for the recruited subjects. Sixty (n=60) subjects, who met the 
inclusion and exclusion criteria, were recruited and underwent MRI brain scanning 
using Philips 3-Tesla Achieva MR scanner as well as completed neuropsychological 
assessment using Wechsler Adult Intelligence Scale (WAIS-IV) (2008). The baseline 
MRI images were used to determine the presence of WMHs and scored using 
Fazekas scale. The neuropsychological testing included three index scales such as 
Perceptual Reasoning Index (PRI), Working Memory Index (WMI) and Processing 
xii 
 
Speed Index (PSI). The analyses were carrying out by IBM SPSS Statistics version 
22.0. Sixty subjects (n=18 males and n=42 females), aged between 25 to 62 years old 
were recruited. Approximately 30% of them had family history of heart attack, 10% 
on hypertension treatment and 60% without comorbidity. Among the subjects, 23 
(38.3%) of them have WHMs on MRI, and the rest appeared normal. Among WMHs 
subjects, 39.1% were in younger age group (25-39) and 60.9% were in the middle-
age (40-62) group. The primary data suggested that the scores of neuropsychological 
test were variable among WMHs subjects, with brain region predilections. There was 
a significant association between subjects with and without WMHs in PRI, t 
(0.07,58)=0.07, p=0.02. Thus, age (r=0.3,p< 0.05) and QRISK scores (r=0.4, p<0.05) 
appeared to be correlated to the presence of WMHs. This result suggests that in older 
people, CSVD may contribute to cognitive decline by affecting information 
processing speed and executive function. Given that presence of WMHs may also 
indicate an increased risk of symptomatic cerebrovascular events, thus careful 
interpretation is required in order to determine its clinical relevance for the individual 
subjects.  
 
 
 
 
 
 
 
 
 
 
1 
 
CHAPTER 1 
CHAPTER 1: INTRODUCTION 
INTRODUCTION 
 
1.1 Study background 
 
Cerebral Small Vessel Disease (CSVD) is related to the changes in the structure 
and function of the brain, mainly in the connective white matter (WM) and 
frequently as ischaemic lesions. The term CSVD has been used to reflect 
clinical, radiological or pathological phenomena attributed to disease of small 
perforating arteries and arterioles supplying deep brain structures. The most 
frequent morphologic findings on brain MRI that related with CSVD include 
white matter hyperintensities (WMHs;leukoaraiosis), small subcortical infarcts, 
and microbleeds. WMHs are the most common manifestations of CSVD. 
Therefore, it is an important clinico-pathological condition that is recognised to 
results in 20% of strokes worldwide, and the most common precursor for 
vascular and mixed dementia (vascular dementia (VaD) and Alzheimer‘s 
disease (AD)); (Pantoni 2010; Philip B. Gorelick et al., 2011).  
 
The spectrum of features seen on neuroimaging by conventional MRI include 
recent small subcortical infarcts, lacunes, white matter changes (WMCs) or 
white matter hyperintensities (WMHs), perivascular spaces, microbleeds, and 
brain atrophy (Pantoni 2010). WMHs (leukoaraiosis) are seen as patchy areas of 
hypodensity on Computed Topography (CT) scans, or hyperintensity on T2-
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weighted, fluid attenuated inversion recovery (FLAIR), and proton density-
weighted images on MRI, including the periventricular and centrum semiovale 
white matter (Haller et al., 2013; Schmahmanna et al., 2008; Wardlaw et al., 
2015a).  
 
On MRI images, the difference between normal and abnormal tissue is often 
clearer compared with CT. In addition, there is no ionizing radiation needed in 
an MRI scan, but it can be a noisy exam and takes longer than a CT. The 
absolute contraindications to MRI involve cardiac pacemakers, cochlear 
implants, implanted stimulators, ferromagnetic implants, aneurysm clips and 
metal in the eye (Sherllock et al., 1993). Therefore, the subjects with  
contraindications of MRI will not be admitted to the scan room due to risk of 
injury. 
 
WMHs are recognised to be ordinary MRI findings in patients with 
cardiovascular risk factors and symptomatic cerebrovascular disease (Li et al., 
2013; Simoni et al., 2012), and have a relationship with increased risk of 
functional decline, dementia, and even death  (De Groot et al., 2000; Debette 
and Markus, 2010; Inzitari et al., 2009; Jeerakathil et al., 2004; Longstreth et 
al., 1996; Pantoni et al., 2005; Prins and Scheltens, 2015; van Dijk et al., 2002). 
However, WMHs have been reported to be prevalent in healthy elderly on MRI 
scans done in selected populations (Sachdev et al., 2005; Yoshita et al., 2005).  
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WMHs characterization in terms of volume, location and number of lesions 
which are assessed either by visual rating scales or quantitative measurements, 
has also been recently included within the standards for reporting vascular 
changes on neuroimaging, both in the routine clinical settings and for research 
purposes (Wardlaw et al., 2013b). There are several visual rating scales used to 
assess WMHs, the common  ones include the Fazekas scale (Fazekas et al., 
1987), the Scheltens scale (Scheltens et al., 1993) and the age-related white 
matter changes (ARWMC) scale (Wahlund et al., 2001). Beyond the routine use 
in clinical settings, these scales are finding purpose in research setting as well 
(Kreisel et al., 2013; Simoni et al., 2012). In this study, Fazekas scale is selected 
as the most widely used method in visual rating and has been in use for over two 
decades to produce an overall impression of WMHs presence in the entire brain. 
 
At present, WMHs are widely regarded to represent the radiological appearance 
of a vascular process linked mainly with cerebral small-vessel changes (Pantoni 
and Garcia, 1997; Pantoni et al., 1999). Although the association between 
WMHs and aging has been consistently shown across different studies (Aine et 
al., 2014; Pantoni and Garcia, 1995; Schmidt, 2005; Smith et al., 2017) 
conflicting conclusions remained as far as other risk factors and clinical 
correlates are concerned. 
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In healthy individuals, executive dysfunction seems to correspond with WMHs 
(DeCarli et al., 1995; O'Brien et al., 2002). The overall severity of WMHs is 
known to link with the reduction in the speed processing and executive 
performance in patients with subcortical ischaemic vascular dementia (Mungas 
et al., 2001). In contrast, such global cognition deficit is not seen in those with  
additional heterogenous vascular dementia (Cohen et al., 2002). Nebes et al 
(2006) found a significant relationship between WMHs severity and processing 
speed in older healthy adults aged 65-80 years (Nebes et al., 2006).  
 
By using Wechsler Adults Intelligence Scale –fourth Edition (WAIS-IV), this 
study assessed Perceptual Reasoning Index (PRI), Working Memory Index 
(WMI) and Processing Speed Index (PSI) for cognitive ability. 
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1.2 Rationale of study  
 
In general, the current study is designed to find the correlation between the 
magnetic resonance image (MRI) finding of CSVD in apparently 
asymptomatic (healthy) individuals and their neurocognitive profiles on 
specific neuropsychological tests. Although there were many previous studies 
which had correlated WMHs MRI finding of CSVD with neurocognitive 
profiles, these had largely been in older adults, dementia and post-stroke 
patients with other specific neurocognitive tests such as Mini Mental State 
Examination (MMSE), Clock Drawing Test and Stroop. The selection of 
WAIS-IV as a neuropsychological test in this study reflected the fact that 
there have been fewer studies on healthy individual for both young adults and 
older adults related to CSVD such as WMHs (Loring and Bauer, 2010a). 
 
Cerebral Small Vessel Disease (CSVD) is not often mortal; however, it does 
influence the quality of life among those affected. CSVD tend to progress 
very slowly (and thus asymptomatic subjects/subclinical) and it tends to 
manifest clinically (i.e symptomatic) only after many years. At present, the 
treatment choice is very restricted and often recommended based on the 
therapeutic principles applied in the larger cerebral artery stroke. Therefore, 
such data may be useful in understanding of the natural history of subclinical 
CSVD and its relation as a predictor of cognitive impairment in apparently 
healthy individuals, and essentially can help guide for wider preventive 
actions in the society. 
  
6 
 
1.3 Objectives and hypotheses of the study 
 
1.3.1 General objective 
To assess the relationship between subclinical CSVD from MRI findings and 
the neuropsychological test performance. 
 
1.3.2 Specific objectives 
 
1. To compare MRI finding with neuropsychological performance. 
2. To determine the association of QRISK2, imaging changes and 
 psychological assessment. 
3. To determine whether QRISK2 predicts the correlation with 
 psychological findings. 
 
1.3.3 Null Hypotheses 
 
1. There are no significant different of MRI finding with neuropsychological 
performance. 
2. There is no significant correlation between QRISK2, imaging changes 
and psychological assessment. 
3. Psychological findings (PRI, WMI and PSI) do not predict QRISK2. 
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1.4 Summary  
 
In summary, this introduction chapter has covered the important areas of the 
research such as the study background, rationale of study as well as objectives 
and hypotheses of the study. 
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CHAPTER 2 
CHAPTER 2: LITERATURE REVIEW 
LITERATURE REVIEW 
 
2.1 Cerebral Small Vessel Disease (CSVD) 
 
 
Cerebral Small Vessel Disease (CSVD) refers to pathological processes that 
affect the structure or function of small vessels on the surface and within the 
brain, including arteries, arterioles, capillaries, venules, and veins (Pantoni 
2010). Two pairs of blood vessels supplying the brain are the vertebral and 
internal carotid arteries which are interconnected in the cranial cavity to 
produce an arterial circle called Circle of Willis (see Figure 2.1). 
Approximately 80% of the total cerebral blood flow are contributed by 
carotid artery, while rest about 20% coming from the vertebral arteries.  
 
CSVD remarkably affects perforating end-arteries branching customarily 
perpendicularly from a large parent artery. In other words, CSVD is 
correlated with structural and functional changes within the brain, mainly in 
the connective white matter (WM), during the development of ischaemic 
lesions. It is also an important clinico-pathological condition that cause of 
20% of strokes worldwide, and the most common causes of vascular and 
mixed dementia [vascular dementia (VaD) and Alzheimer‘s disease (AD)] 
(Gorelick et al., 2011; Pantoni 2010). 
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Neuroimaging is used as a method to detect the consequences of pathological 
changes of small vessels to the brain. These consequences comprise white 
matter hyperintensities, small infarctions or hemorrhages in white or deep 
grey matter, enlargement of perivascular spaces, and brain atrophy (Wardlaw 
et al., 2013a). 
 
Figure 2. 1 : Arterial Circle on Base of Brain (adapted from (Hansen, 2014)). 
 
2.2 White Matter Hyperintensities (WMHs) 
 
White matter is composed of millions of bundles of axons (nerve fibres) that 
connect neurons in different brain regions into functional circuits which lie 
beneath the grey matter cortex. The white colour is derived from the electrical 
insulation (myelin) that coats the axons and formed by non-neuronal cells, 
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oligodendrocytes, which wrap up to 150 layers of tightly compressed cell 
membrane around axons (Field, 2010). The location of white matter in the 
brain includes the central and subcortical regions of the cerebral and 
cerebellar hemispheres. Thus it accounts for about 60% of the total brain 
volume. White matter changes  known as leukoaraiosis are generally referred 
to as a periventricular white matter disease, or WMHs, due to their bright 
white appearance on T2-weighted MRI scans (Kim et al., 2014)(see Figure 
2.2). In addition, they are identified on Computed Tomography (CT) as 
diffuse areas of hypodensity, and high signal intensities on T2-weighted, 
proton density and fluid-attenuated inversion recovery (FLAIR) images. 
Hence on T1-weighted images, they can be presented as isointense or 
hypointense according to the severity of the underlying pathological changes 
(Seiler et al., 2012). 
 
WMHs are categorized into two groups based on their anatomical location; 
the ventricles and deep white matter (Fazekas et al., 2002). They are typically 
related with age, hypertension and other cardiovascular risk factors 
(Longstreth et al., 1996). Thus, the prevalence of WMHs ranges in adults 
aged 64 raises from 11-12% and increases about 94% in adults at age 84 
(Thompson and Hakim, 2009). Incidental WMHs are common in brains of 
healthy people in their 60s and may be identifying as early as the 30s and 40s. 
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Figure 2.2 : Diagram of dynamic mechanisms by which WMHs and CSVD lead to 
        brain damage (adapted from (Wardlaw et al., 2015b)). 
 
 
2.3 Aetiology and consequences of WMHs 
 
WMHs were first described as radiological finding in 1986 (Pantoni, 2008) 
and was followed by attempts to contribute a pathological description 
(Wardlaw et al., 2013b). The aetiology of WMHs is still unclear, despite 
there are progressively histopathological, epidemiological, and physiological 
studies that contribute important information about it.  
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Healthy white matter is more myelinated than white matter of Alzheimer 
patients (Bartzokis G et al., 2003) and has a high content of long-chain fatty 
acids and less 12% of water compared with grey matter. Previous studies 
have reported that WMHs are consistently related with age, hypertension, and 
other cardiovascular risk factors (Prabhakaran et al., 2012). Therefore, 
individual with extensive WMHs are at high risk for future stroke. 
Nevertheless, WMHs occurs around 30% of healthy subjects over 60 years of 
age, and their prevalence show a steady rise with increasing age (Meyer et al., 
1992).  
 
Brain atrophy, reduced cerebral blood flow and focal neurologic signs have 
been found to be correlated with volume and number of WMHs (DeCarli et 
al., 1995). Roman (1987) reported that WMHs associated with cognitive 
impairment, with a suggestion that a certain threshold must be achieved 
before this becomes clinically apparent (Roman, 1987). WMHs are also 
related with major depression, bipolar disorder and schizophrenia (Sachdev 
and Brodaty, 1999). 
 
Since the progression of WMHs is related to aging (Prins and Scheltens, 
2015) testing the brain of individuals in middle age offers the opportunity to 
determine the distribution of lesions in their early phase while provides a 
baseline for the examination of the impact of age, hypertension, diabetes and 
other risk factors as the severity and distribution of WMHs. 
 
 
13 
 
2.4 WMHs and cognitive function 
  
Junque et al.(1990) reported that WMHs were correlated with cognitive 
impairment (Junqué et al., 1990). On neuroimaging, with high prevalence of 
WMHs, even in healthy elderly population without cognitive impairment, 
Fazekas et al (2009) argued that WMHs were unlikely to be associated with 
cognitive performance and decline (Fazekas et al., 2009). 
 
O‘Brien (2006)  pointed out that patients with moderate to severe WMHs 
might present a high risk of lesion progression and as a result of clinical 
decline in vascular cognitive impairment (O'Brien, 2006). Furthermore, 
Reinhold Schmidt et al (2010)  reported that people with moderate and severe 
WMHs did not show differences in performances on mini-mental state 
examination (MMSE) and executive function tasks (Reinhold Schmidt et al., 
2010). 
 
Cognitive domains were highly correlated with brain volume, but the 
relationships between WMHs volume and cognition were considered low 
(Benjamin et al., 2014). In other studies done by Oosterman et al. found a 
significant relationship between WMHs and fronto-executive functions in a 
subject with risk factors for cerebrovascular disease that inhibitory control, 
planning and working memory (Oosterman et al., 2008). They also noted that 
hippocampal atrophy was also correlated with executive function, showing a 
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high input to performance in working memory and set-shifting tasks 
(Oosterman et al., 2008).  
 
2.5 Magnetic Resonance Imaging (MRI) 
 
A magnetic resonance imaging (MRI) scan is a common procedure used by 
all hospitals around the world and is the most sensitive tool to assess CSVD. 
By providing detailed non-invasive images of the brain, MRI has transformed 
from routine clinical use to the tool for furthering research into the functional 
and structural of changes in healthy and diseased brain. Images of the human 
body that provided by MRI were sliced same as a loaf of bread can be in any 
direction, as well as thin as a couple of millimeters. It also provides better 
soft tissue contrast compared to Computed Tomography (CT) and make 
differentiated  fat, water, muscle, and other soft tissue better than CT. Thus, it 
is the best way to view the soft tissues especially brain and without any 
exposure to radiation. 
 
The basic protocol to neuroimaging set up of WMHs is the combination of 
T1-weighted, T2-weighted and FLAIR sequences. T1-weighted sequences are 
very useful and informative structural MRI methods. Later T1-weighted 
sequences create images which maximize the contrast among grey matter 
(GM), WM and cerebrospinal fluid (CSF). By viewing these images, CSF 
shows hypointense (dark) and GM has less intensity (appears darker) 
compared with WM.  
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In addition, T2-weighted and FLAIR images are also important structural 
views for MRI sequences. On T2-weighted image of normal MRI, grey 
matter is seen brighter than white matter together with hyperintensity of CSF. 
However, in small lesion of brain, the similar finding of hyperintensity of 
CSF could also be presented. This can lead to confusion when interpreting the 
result. FLAIR images are T2-weighted image where CSF signal is perfectly 
suppressed while lesions still appear hyperintense, which allows the optimal 
visualization and contrast of WM abnormalities such as WMHs (Fazekas et 
al., 2002). 
 
2.6 MRI grading of WMHs severity 
 
Currently, there are diverse of techniques to quantify the presence of WMHs on 
MRI ranging from visual rating scales to semi-automated or fully automated 
volumetric. WMHs are composed of deep white-matter hyperintensities 
(DWMH) and periventricular hyperintensities (PVH). The WMHs severity can 
be rated visually on axial FLAIR images using various scale such as the 
Fazekas rating scale, Scheltens rating scale, Wahlund rating scale, Ylikoski and 
Manolio (see Table 2.1). 
 
Visual rating is fast and can be used for images of different quality obtained on 
different scanner. In clinical practice and research involving large subjects, it is 
preferable to use visual rating scales than of more time-consuming quantitative 
measurements to assess WMHs. However, visual rating scales inevitably have 
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some limitations, including non-linearity of data, lack of sensitivity to small 
changes, and susceptibility to ceiling effects (Kim et al., 2008). In addition, 
existing scales are heterogeneous, which may be contributed to the dissimilar 
results in previous research on WMHs (Kloppenborg et al., 2014). 
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Table 2.1 : Summary of  visual scales of  MRI for WMHs (adapted from (Issac et al., 2016)). 
Scales for MRI  
(WMH) 
Assessment of severity Scores 
Fazekas  Periventricular and deep WMCs are rated separately. A total score is obtainable by summing the 2 partial 
scores. 
Periventricular hyperintensities Scores are as follows: 0 = absence, 1 = ―caps‖ or pencil-thin lining, 2 = 
smooth ―halo,‖ and 3 =irregular periventricular hyperintensities extending into the deep white matter. 
Deep white matter hyperintense signals Scores are as follows: 0 = absence, 1 = punctuate foci, 2 = 
beginning confluence of foci, and 3 =large confluent areas. 
 
Total score 
minimum, 0; 
maximum, 6 
Modified 
Scheltens   
Periventricular hyperintensities (minimum, 0; maximum 6) 
Scoring is as follows: caps, occipital 0/1/2, and frontal 0/1/2; bands, lateral ventricles 0/1/2  
(0 =absent, 1 = ≤5 mm, 2 = ≥6 mm, and ≤10 mm). 
White matter hyperintensities(minimum, 0; maximum, 24) 
Scoring is as follows: frontal 0/1/2/3/4/5/6, parietal 0/1/2/3/4/5/6, occipital 0/1/2/3/4/5/6, and 
temporal 0/1/2/3/4/5/6 (0 = no abnormalities; 1 = ≤3 mm, 𝑛 ≤ 5; 2 = ≤3 mm, 𝑛 ≤ 6; 3 = 4 to 
10 mm, 𝑛 ≤ 5; 4 = 4 to 10mm, 𝑛 ≥ 6; 5 = ≥11 mm, 𝑛 ≥ 1; 6 = confluent). 
 
Minimum, 0; 
maximum, 30 
Ylikoski  WMCs located at 4 locations (frontal horns, body of the ventricles, trigones, and occipital horns) are rated 
separately on each hemisphere. 
Periventricular leukoaraiosis (minimum, 0; maximum, 24) 
Scoring is as follows: 0 = no hyperintensity; 1 = punctuate, small foci (mild); 2 = cap,pencil-thin lining 
(moderate); and 3 = nodular band, extending hyperintensity (severe). Centrum semiovale leukoaraiosis, 
including watershed areas (minimum, 0; maximum, 24) 
Scoring is as follows: 0 = no hyperintensity; 1 = punctuate, small foci (mild); 2 = beginning confluent 
(moderate); and 3 = large confluent areas (severe). Total leukoaraiosis score is periventricular leukoaraiosis 
score plus centrum semiovale leukoaraiosis score equal to 0 to 48. 
Minimum, 0; 
maximum 48 
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Table 2.1 : Summary of  visual scales of  MRI for WMHs (adapted from(Issac et al., 2016). (continued)) 
Scales for MRI  
(WMH) 
Assessment of severity Scores 
Manolio  Periventricular and subcortical regions are not rated separately. Including 9 grades:  
 
0 = no white matter signal abnormalities; 1 = discontinuous periventricular rim or minimal ―dots‖ of 
subcortical white matter; 2 = thin, continuous periventricular rim or few patches of subcortical white matter 
lesions; 3 = thicker continuous periventricular rim with scattered patches of subcortical white matter 
lesions; 4 = thicker shaggier periventricular rim and mild subcortical white matter lesions and may have 
minimal confluent periventricular lesions; 5 = mild,periventricular confluence surrounding frontal and 
occipital horns; 6 = moderate periventricular confluence surrounding frontal and occipital horns; 7 = 
periventricular confluence with moderate involvement of centrum semiovale; 8 = periventricular confluence 
involving most of centrum semiovale; and 9 = all white matter involved. 
 
Minimum, 0; 
maximum, 9 
Wahlund  Deep white matter lesions (WMLs) and periventricular hyperintensity combined and called WMLs: 
1 = No white matter changes; 1.5 = Small solitary white matter changes; 2 = Multiple discrete or large 
solitary white matter changes; 2.5 = Multiple, partly confluent white matter changes; 3 = Multiple, large 
confluent white matter changes. 
 
Minumum, 1; 
maximum, 3. 
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2.6.1 Fazekas Scale 
 
Fazekas rating scale rates periventricular and deep WML separately. 
Periventricular hyperintensities are scored as: 0 = absence, 1 = ‗caps‘ or 
pencil-thin lining, 2 = smooth ‗halo‘ and 3 = irregular periventricular 
hyperintensities extending into the deep white matter. Deep white matter 
hyperintensities are scored as: 0 = absence, 1 = punctuate foci, 2 = beginning 
confluence of foci and 3 = large confluent areas. A range of total score is 
from 0 to 6 was obtained by total both periventricular and deep WMHs 
Fazekas scores (see Figure 2.3). 
 
Fazekas scale is one of the most widely used visual rating scales and has been 
in use for over two decade. It is the simplest WMHs scale. Hence, this scale 
is also closely associated with quantitative measures of WMHs volumes 
(Valdes Hernandez Mdel et al., 2013). 
 
 
Figure 2.3 : Subcortical hyperintensities on MRI, ranging in severity from 
none (left), through mild and moderate, to severe (right). (Adapted from 
(Malloy et al., 2006)). 
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2.7 Conventional risk factors for cerebrovascular diseases 
  
Risk factors for cerebrovascular disease in the population setting were first 
recognised in the Framingham Heart Study in the early 1960s (Syed S 
Mahmood et al., 2014). The prevention of cardiovascular morbidities and 
mortality is critical by understanding of such factors. Age, gender, race, 
ethnicity, and heredity have been recognized as risk for stroke. Although 
these factors cannot be modified, they help identify those at high risk, 
enabling vigorous treatment of those risk factors that can be adjusted. 
 
The strongest determinant risk factor for stroke is age. For every successive 
10 years after age 55 years old, the rate to get stroke is more than doubles in 
both men and women (Brown et al., 1996; Wolf et al., 1992). Furthermore, 
stroke incidence rates are 1.25 times higher in men compared to women 
because women tend to live longer than men (Wong, 1999). 
 
Between racial groups, stroke incidence and mortality rates widely varied. 
According to several studies, stroke incidence is higher among black patients, 
approximately double compared with white patients. The study in Manhattan 
by Sacco et al. found that stroke incidence among black patients was 2.4 
times more than white patients; while among Hispanic patients were 1.6 
times compared with white patients (Sacco et al., 1998). In Asians, Chinese 
and Japanese, higher incidence rates of stroke had been reported (Ueshima et 
al., 2008).  
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Stroke incidence also increased with a family history of stroke. The reasons 
of this are a genetic tendency for stroke, a genetic determination of other 
stroke risk factors, and a common familial exposure to environmental or 
lifestyle risks. Earlier studies suggested an increased risk for men whose 
mothers died of stroke and women who had a family history of stroke 
(Seshadri et al., 2010). In the Framingham Study an offspring analysis 
revealed that both paternal and maternal history of stroke was related with an 
increased risk of stroke (Kiely et al., 1993). 
 
Currently, an online calculator has been established to predict the risk for 
cerebrovascular disease within 10 years, including QRISK2 (Collins and 
Altman, 2010).  
 
2.7.1 QRISK2 
 
QRISK2 is an online based risk prediction of cardiovascular disease (Collins 
and Altman, 2010). (http//:www.QRISK.org/index.php) (University of 
Nottingham and EMIS). It was developed in the United Kingdom (UK) based 
on information compiled between 1993 and 2010 that contained the data for 
over 10 million patients registered with 550 general practices in the UK. 
Hence, it is used internationally and is updated annually.  
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QRISK2, the updated version of QRISK1, is a new multivariable risk score 
that comprises all the risk factors in QRISK1 including self-assigned 
ethnicity and conditions associated with cardiovascular risk (including 
diagnosed type 2 diabetes, treated hypertension, rheumatoid arthritis, renal 
disease, and atrial fibrillation) (Hippisley-Cox et al., 2008). Interactions 
between age and Townsend score, body mass index, systolic blood pressure, 
family history, smoking status, treated hypertension, diagnosis of type 2 
diabetes, and atrial fibrillation also are considered in QRISK2 (see Table 2.2). 
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Table 2.2 : Summary the risk factors in QRISK1 and QRISK2 adapted from 
(Collins and Altman, 2010) 
QRISK1 
 
Age (continuous) 
Ratio of total serum cholesterol:high density lipoprotein (continuous) 
Systolic blood pressure (continuous) 
Smoking status (current smoker/non-smoker (including former smoker)) 
Body mass index (continuous) 
Family history of coronary heart disease in first degree relative under 60 
years (yes/no) 
Townsend deprivation score (output area level 2001 census data evaluated as 
continuous variable) 
Receiving treatment for blood pressure at baseline (at least one current 
prescription of at least one antihypertensive agent) (yes/no) 
Systolic blood pressure × Receiving treatment for blood pressure at baseline 
 
QRISK2 
 
Age (continuous) 
Ratio of total serum cholesterol:high density lipoprotein (continuous) 
Systolic blood pressure (continuous) 
Smoking status (current smoker/non-smoker (including former smoker)) 
Body mass index (continuous) 
Family history of coronary heart disease in first degree relative under 60 
years (yes/no) 
Townsend deprivation score (output area level 2001 census data evaluated as 
continuous variable) 
Treated hypertension (diagnosis of hypertension and at least one current 
prescription of at least one antihypertensive agent) (yes/no) 
Self- assigned ethnicity (white (or not 
recorded)/Indian/Pakistani/Bangladeshi/ other 
Asian/black African/black Caribbean/other (including mixed)) 
Type 2 diabetes (yes/no) 
Rheumatoid arthritis (yes/no) 
Atrial fibrillation (yes/no) 
Renal disease (yes/no) 
Age × body mass index 
Age × Townsend score 
Age × systolic blood pressure 
Age × family history of cardiovascular disease 
Age × smoking current 
Age × treated hypertension 
Age × type 2 diabetes 
Age × atrial fibrillation 
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2.8 Neuropsychological tests 
 
Neuropsychological tests are specially designed tasks to examine brain 
function and cognitive abilities. There are many kinds of neuropsychological 
tests that evaluate functioning in a number of areas, such as: intelligence, 
executive functions (such as planning, abstraction and conceptualization), 
attention, memory, language, perception, sensorimotor functions, motivation, 
mood state and emotion, quality of life, and personality styles  (Philip, 2012). 
 
Now, most of the neuropsychological tests are based on traditional 
psychometric theory that includes the measurement of knowledge, abilities, 
attitudes and personality traits. There are wide varieties of 
neuropsychological tests with different functions and purposes (see Table 
2.3). The Wechsler Scales such as the Wechsler Adult Intelligence Scales, 
Wechsler Intelligence Scale for Children, and Wechsler Memory Scales are 
among the commonly used tests. The Halstead-Reitan Battery and the 
California Verbal Learning Test which is under The Trail-Making Test are 
frequently used to test of auditory supraspan memory. The Halstead-Reitan 
Battery (HRB) is the commonly used neuropsychological test battery that 
being utilized by approximately 15% of the neuropsychologists surveyed 
(Rabin LA et al., 2005). The top 10 tests administered are the Rey Ostereith 
Complex Figure Test that is a test for construction, planning and visual 
memory, the Wisconsin Card Sort Test for executive functioning test, and 
tests of supraspan auditory learning are the Rey Auditory Verbal Learning 
Test (RAVLT). 
